Bladder health among older adults is an emerging priority within geriatric medicine and public health, yet it is frequently overshadowed by persistent ...
Johnson & Johnson has revealed early clinical data with a new formulation of its FGFR inhibitor erdafitinib that suggests it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results